Shanghai EA Therapeutics

Shanghai EA Therapeutics (also known as Yi An Bo) is a biotechnology company specializing in exosome-based technology for cancer diagnostics and therapeutics. The company has developed a proprietary platform, Exo-P, for the high-purity isolation and multi-dimensional analysis of extracellular vesicles (exosomes) from blood samples, enabling early detection and monitoring of various cancers. Beyond its diagnostic portfolio, EA Therapeutics is advancing a pipeline of exosome-based drug delivery systems designed to transport therapeutic payloads, such as RNA and small molecules, directly to tumor cells. Based in Shanghai, the company integrates liquid biopsy technology with bioinformatics to provide precision medicine solutions for oncology.